Skip to content

Characterization of Colorectal Neoplasia

The CHANGE Study: Characterization Helping the Assessment of Colorectal Neoplasia in Gastrointestinal Endoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04884581
Acronym
CHANGE
Enrollment
165
Registered
2021-05-13
Start date
2021-05-12
Completion date
2021-08-05
Last updated
2021-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyp

Brief summary

This is a post-marketing, single-arm, prospective study investigating the use of GI Genius CADx device in the real-time characterization of colorectal polyps (i.e. prediction of their histology during the colonoscopy). Patients enrolled will undergo a standard white-light colonoscopy with the support of the latest version of the CE-marked GI Genius CADx device. Colonoscopy will be performed according to the standard practice.

Interventions

DEVICEGI Genius CADx device

GI Genius System is an Intelligent Endoscopy Module designed to be an adjunct to video colonoscopy with the purpose of supporting the operating physician with artificial intelligence during colonoscopy. GI Genius CADx is the AI software that provides a histology prediction of framed polyps during real-time colonoscopy, with each polyp being classified as adenoma or non-adenoma.

Sponsors

Nuovo Regina Margherita Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 40 years or older undergoing screening colonoscopy for CRC * Ability to provide written, informed consent (approved by EC) and understand the responsibilities of trial participation

Exclusion criteria

* subjects at high risk for colorectal cancer * subjects with a personal history of CRC, IBD or hereditary polyposis or non-polyposis syndromes * patients with previous resection of the sigmoid rectum * patients on anticoagulant therapy, which precludes resection / removal operations due to histopathological findings * patients who perform an emergency colonoscopy

Design outcomes

Primary

MeasureTime frameDescription
Negative Predictive Value (NPV)4 monthsNegative Predictive Value (NPV) of GI Genius CADx optical diagnosis on diminutive (≤5 mm) rectosigmoid polyps

Other

MeasureTime frameDescription
Post-polypectomy surveillance interval4 monthsAgreement in assignment of post-polypectomy surveillance intervals of the enrolled patients according to established guidelines between the combined use of GI Genius CADx as optical diagnosis for diminutive (≤5 mm) polyps and conventional histology as diagnostic tool for polyps \> 5 mm, and histology as diagnostic tool for all the resected polyps (regardless of size or location)
Performance metrics of GI Genius CADx4 monthsSensitivity, Specificity, Accuracy, PPV and NPV of GI Genius CADx optical diagnosis
Performance metrics of the endoscopist with the aid of GI Genius CADx4 monthsSensitivity, Specificity, Accuracy, PPV and NPV of the optical diagnosis of endoscopists assessing lesions in white-light with the help of GI Genius CADx.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026